As such, high protein levels of YB-1 and MTA1 in PIN may predispose patients to a more aggressive prostate cancer when it develops, thereby increasing the risk for PSA recurrence or the need for future therapy after a prostatectomy. The gene discussed is YBX1; the disease is prostate cancer.